Non Clear Cell Renal Cell Carcinoma clinical trials

Explore recruiting non clear cell renal cell carcinoma clinical trials.

Recruiting non clear cell renal cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Non Clear Cell Renal Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Single-arm, Open-label Clinical Trial of Pembrolizumab Plus Lenvatinib in Participants with First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (nccRCC) (KEYNOTE-B61)

Italy, Spain, Hungary, Poland, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma

Denmark, Finland, France, Spain, Netherlands, Poland +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase II trial of an individualized treatment strategy for patients with metastatic non-clear cell renal carcinoma

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A Dose-Escalation and Expansion Study of the Safety and Pharmacokinetics of XL092 as Single-Agent and Combination Therapy in Subjects with Inoperable Locally Advanced or Metastatic Solid Tumors

Czechia, Spain, Belgium, France, Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Non Clear Cell Renal Cell Carcinoma trials by city

Non Clear Cell Renal Cell Carcinoma in Toronto Non Clear Cell Renal Cell Carcinoma in Vancouver Non Clear Cell Renal Cell Carcinoma in Montreal Non Clear Cell Renal Cell Carcinoma in Calgary Non Clear Cell Renal Cell Carcinoma in Edmonton Non Clear Cell Renal Cell Carcinoma in Ottawa Non Clear Cell Renal Cell Carcinoma in Winnipeg Non Clear Cell Renal Cell Carcinoma in Quebec City Non Clear Cell Renal Cell Carcinoma in Hamilton Non Clear Cell Renal Cell Carcinoma in Kitchener Non Clear Cell Renal Cell Carcinoma in London Non Clear Cell Renal Cell Carcinoma in Halifax Non Clear Cell Renal Cell Carcinoma in New York Non Clear Cell Renal Cell Carcinoma in Los Angeles Non Clear Cell Renal Cell Carcinoma in Chicago Non Clear Cell Renal Cell Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease